Tenet Healthcare Corp THC
2 targets with a reported result
Releases of the last 3 yearsThe numbers THC said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $4.49B to $4.79B release Feb 11, 2026
Kept $4.49B to $4.79B release Apr 30, 2026
Raised $4.83B to $5.03B release Jul 23, 2026
Raised $5.05B to $5.20B release Oct 29, 2026
|
– | No standard number | |
The company's wordsFY 2026 Adjusted EBITDA Outlook is expected to be in the range of $4.485 billion to $4.785 billion release Feb 11, 2026 FY 2026 Adjusted EBITDA Outlook continues to be in the range of $4.485 billion to $4.785 billion release Apr 30, 2026 FY 2026 Adjusted EBITDA Outlook is now expected to be in the range of $4.83 billion to $5.03 billion, a $295 million increase at the midpoint of the range; release Jul 23, 2026 FY 2026 Adjusted EBITDA Outlook is now expected to be in the range of $5.05 billion to $5.20 billion, a $195 million increase at the midpoint of the range; release Oct 29, 2026 | ||||
| Free cash flow (company-defined) Fiscal 2026 |
Given $2.73B to $3.02B release Jul 23, 2026
Raised $2.83B to $3.12B release Oct 29, 2026
|
– | No standard number | |
The company's wordsFY 2026 Adjusted Free Cash Flow outlook now expected to be in the range of $2.725 billion to $3.025 billion, a $225 million increase release Jul 23, 2026 FY 2026 Adjusted Free Cash Flow outlook now expected to be in the range of $2.825 billion to $3.125 billion, a $100 million increase release Oct 29, 2026 | ||||
| Diluted EPS Fiscal 2026 |
Given $29.60 to $32.27 release Feb 11, 2026
Raised $29.94 to $32.64 release Apr 30, 2026
Raised $34.57 to $36.43 release Jul 23, 2026
Raised $35.82 to $37.08 release Oct 29, 2026
|
– | Not reported yet | |
The company's wordsTenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Diluted income per common share $29.60 to $32.27 release Feb 11, 2026 Tenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Diluted income per common share $29.94 to $32.64 release Apr 30, 2026 Tenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Diluted income per common share $34.57 to $36.43 release Jul 23, 2026 Tenet’s Outlook for full year 2026 (consolidated and by segment) follows. … Diluted income per common share $35.82 to $37.08 release Oct 29, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $16.19 to $18.47 release Feb 11, 2026
Raised $16.38 to $18.68 release Apr 30, 2026
Raised $20.30 to $21.69 release Jul 23, 2026
Raised $22.05 to $23.01 release Oct 29, 2026
|
– | No standard number | |
The company's wordsTenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $16.19 to $18.47 release Feb 11, 2026 Tenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $16.38 to $18.68 release Apr 30, 2026 Tenet’s Outlook for full year 2026 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $20.30 to $21.69 release Jul 23, 2026 Tenet’s Outlook for full year 2026 (consolidated and by segment) follows. … Adjusted diluted earnings per share $22.05 to $23.01 release Oct 29, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $3.98B to $4.17B release Feb 12, 2025
Kept $3.98B to $4.17B release Apr 29, 2025
Raised $4.40B to $4.54B release Jul 22, 2025
Raised $4.47B to $4.57B release Oct 28, 2025
|
– | No standard number | |
The company's wordsFY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion release Feb 12, 2025 FY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion release Apr 29, 2025 FY 2025 Adjusted EBITDA Outlook is now expected to be in the range of $4.40 billion to $4.54 billion, a $395 million increase at the midpoint release Jul 22, 2025 FY 2025 Adjusted EBITDA Outlook is now expected to be in the range of $4.47 billion to $4.57 billion, a $50 million increase at the midpoint release Oct 28, 2025 | ||||
| Diluted EPS Fiscal 2025 (ended Dec 31, 2025) |
Given $10.95 to $12.47 release Feb 12, 2025
Raised $11.37 to $12.92 release Apr 29, 2025
Raised $14.05 to $15.15 release Jul 22, 2025
Raised $14.66 to $15.37 release Oct 28, 2025
|
$15.49 10-K filed 2026-02-17 |
Above the range | |
The company's wordsTenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Diluted income per common share $10.95 to $12.47 release Feb 12, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Diluted income per common share $11.37 to $12.92 release Apr 29, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Diluted income per common share $14.05 to $15.15 release Jul 22, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Diluted income per common share $14.66 to $15.37 release Oct 28, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $11.74 to $12.84 release Feb 12, 2025
Raised $11.99 to $13.12 release Apr 29, 2025
Raised $15.55 to $16.21 release Jul 22, 2025
Raised $15.93 to $16.26 release Oct 28, 2025
|
– | No standard number | |
The company's wordsTenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $11.74 to $12.84 release Feb 12, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $11.99 to $13.12 release Apr 29, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $15.55 to $16.21 release Jul 22, 2025 Tenet’s Outlook for full year 2025 ( consolidated and by segment) follows. … Adjusted diluted earnings per share $15.93 to $16.26 release Oct 28, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $3.29B to $3.48B release Feb 8, 2024
Raised $3.50B to $3.70B release Apr 30, 2024
Raised $3.83B to $3.98B release Jul 24, 2024
Raised $3.90B to $4.00B release Oct 29, 2024
|
– | No standard number | |
The company's wordsFY 2024 Adjusted EBITDA Outlook is expected to be in the range of $3.285 billion to $3.485 billion and reflects the closing of the South Carolina hospital sale as of January 31, 2024 and assumes the closing of the California hospital sale on March 31, 2024 release Feb 8, 2024 FY 2024 Adjusted EBITDA Outlook now expected to be in the range of $3.5 billion to $3.7 billion, a $215 million increase release Apr 30, 2024 FY 2024 Adjusted EBITDA Outlook now expected to be in the range of $3.825 billion to $3.975 billion, a $300 million increase; release Jul 24, 2024 FY 2024 Adjusted EBITDA Outlook now expected to be in the range of $3.9 billion to $4.0 billion, a $50 million increase release Oct 29, 2024 | ||||
| Free cash flow (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $1.10B to $1.35B release Jul 24, 2024
Lowered $175.00M release Oct 29, 2024
|
– | No standard number | |
The company's wordsFY 2024 Free Cash Flow outlook now expected to be in the range of $1.100 billion to $1.350 billion, a $150 million increase release Jul 24, 2024 Our outlook for full year 2024 net cash provided by operating activities and free cash flow 1 now reflects the anticipated payment of approximately $175 million of income taxes, primarily in connection with the net gain on the sale of these facilities. release Oct 29, 2024 | ||||
| Diluted EPS Fiscal 2024 (ended Dec 31, 2024) |
Given $20.69 to $23.02 release Feb 8, 2024
Raised $25.96 to $27.35 release Apr 30, 2024
Raised $28.83 to $29.90 release Jul 24, 2024
Raised $31.56 to $32.58 release Oct 29, 2024
|
$32.70 10-K filed 2025-02-18 |
Above the range | |
The company's wordsThis outlook reflects the completion of the sale of our Coastal South Carolina hospitals on January 31, 2024 and assumes that the sale of our four California hospitals will be completed on March 31, 2024. … Diluted income per common share from continuing operations $20.69 to $23.02 release Feb 8, 2024 This outlook reflects the completion of the sale of three Coastal South Carolina hospitals on January 31, 2024 and the completion of the sale of six California hospitals on March 31, 2024. … Diluted income per common share from continuing operations $25.96 to $27.35 release Apr 30, 2024 This outlook reflects the completion of the sale of three Coastal South Carolina hospitals on January 31, 2024 and the completion of the sale of six California hospitals on March 31, 2024. … Diluted income per common share $28.83 to $29.90 release Jul 24, 2024 This outlook reflects the sale of three Coastal South Carolina hospitals on January 31, 2024, the sale of six California hospitals on March 31, 2024, and the sale of five Alabama hospitals on September 30, 2024. … Diluted income per common share $31.56 to $32.58 release Oct 29, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $10.41 to $11.12 release Jul 24, 2024
Raised $11.12 to $11.73 release Oct 29, 2024
|
– | No standard number | |
The company's wordsThis outlook reflects the completion of the sale of three Coastal South Carolina hospitals on January 31, 2024 and the completion of the sale of six California hospitals on March 31, 2024. … Adjusted diluted earnings per share $10.41 to $11.12 release Jul 24, 2024 This outlook reflects the sale of three Coastal South Carolina hospitals on January 31, 2024, the sale of six California hospitals on March 31, 2024, and the sale of five Alabama hospitals on September 30, 2024. … Adjusted diluted earnings per share $11.12 to $11.73 release Oct 29, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2024-02-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/THC/export.csv") into a cell.